These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 4208289)

  • 21. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
    J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.
    Karney W; Holmes KK; Turck M
    Antimicrob Agents Chemother; 1973 Mar; 3(3):338-42. PubMed ID: 4275226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C; Crevatin E
    Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics.
    Holmes RK; Minshew BH; Gould IK; Sanford JP
    Antimicrob Agents Chemother; 1974 Sep; 6(3):253-62. PubMed ID: 15830470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro study of netilmicin compared with other aminoglycosides.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
    Clark RB; Sanders CC; Pakiz CB; Hostetter MK
    Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of netilmicin compared with those of gentamicin and tobramycin against enterobacteria and Pseudomonas aeruginosa.
    Chadwick P; Salmon S; Taylor B
    Antimicrob Agents Chemother; 1977 Sep; 12(3):301-7. PubMed ID: 410361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on in vitro activity of the antibiotics tobramycin and gentamicin against Pseudomonas aeruginosa clinical strains.
    Dámaso D; Moreno-López M
    J Antibiot (Tokyo); 1973 Apr; 26(4):233-7. PubMed ID: 4205651
    [No Abstract]   [Full Text] [Related]  

  • 33. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of methylxanthines and gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa: role of phosphodiesterase inhibition.
    Bazzaz BS; Lavaei S; Hosseinzadeh H
    Acta Microbiol Immunol Hung; 2012 Mar; 59(1):13-20. PubMed ID: 22510283
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics.
    Wretland B; Nord CE; Wadström T
    Scand J Infect Dis; 1974; 6(1):49-52. PubMed ID: 4208204
    [No Abstract]   [Full Text] [Related]  

  • 38. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of Pseudomonas aeruginosa infections with tobramycin.
    Blair DC; Fekety FR; Bruce B; Silva J; Archer G
    Antimicrob Agents Chemother; 1975 Jul; 8(1):22-9. PubMed ID: 809002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.